Virtus LifeSci Price Prediction and Hype Density Breakdown

BBC -- USA Etf  

USD 25.32  0.21  0.84%

We analyze noise-free headlines and recent hype associated with Virtus LifeSci Biotech Clinical Trls ETF which may create opportunities for some arbitrage if properly timed. With Virtus LifeSci hype-based prediction module you can estimate the value of Virtus LifeSci Biotech Clinical Trls ETF from the prospective of Virtus LifeSci response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Virtus LifeSci over a specific investment horizon. Check also Virtus LifeSci Basic Forecasting Models to cross-verify your projections.
Horizon     30 Days    Login   to change

Virtus LifeSci After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

Virtus LifeSci Estimiated After-Hype Price Volatility

January 16, 2019
Current Value
After-hype Price
Target Odds
Odds Odds
Virtus LifeSci is not very risky asset. Analysis and calculation of next after-hype price of Virtus LifeSci Biotech is based on 2 months time horizon.

Virtus LifeSci Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.04% 2.75% 0.01%  0.01% 1 Events / Month0 Events / MonthVery soon
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Virtus LifeSci Hype Timeline

On 16 of January Virtus LifeSci Biotech is traded for 25.32. The entity has historical hype elasticity of -0.01 and average elasticity to hype of competition of 0.01. Virtus LifeSci Biotech Clinical Trls ETF is estimated to decline in value after the next headline with price expected to drop to 25.31. The average volatility of media hype impact on the company stock price is about 1399.49%. The closing price depreciation on the next news is expected to be -0.04% where as daily expected return is currently at -0.04%. The volatility of related hype on Virtus LifeSci is about 1165.25% with expected price after next announcement by competition of 25.33. The company has price-to-book (P/B) ratio of 1.75. Some equities with similar Price to Book (P/B) outperform the market in the long run. Virtus LifeSci Biotech had not issued any dividends in recent years. Considering 30-days investment horizon, the next estimated press release will be very soon.
Check also Virtus LifeSci Basic Forecasting Models to cross-verify your projections.

Virtus LifeSci Related Hype Analysis

At Risk
Health Care Select Sector SPDR ETF 0.00 0 per month 0.00  0.0353  2.41 (2.45)  9.02 
Vanguard Health Care ETF(0.03) 1 per month 0.00  0.0182  2.55 (2.54)  9.33 
iShares Nasdaq Biotechnology ETF 2.48 1 per month 1.87  0.12  3.35 (3.03)  7.64 
SPDR SP Biotech ETF(0.09) 1 per month 2.61  0.1  5.35 (4.25)  10.03 
iShares US Medical Devices ETF 0.00 0 per month 0.00  0.05  3.66 (3.11)  11.18 
First Trust NYSE Arca Biotech ETF 0.00 0 per month 2.07  0.09  3.50 (3.69)  7.57 
iShares US Healthcare ETF 0.00 0 per month 0.00  0.0278  2.50 (2.59)  9.25 
First Trust Health Care AlphaDEX ETF 0.00 0 per month 0.00  0.0028  3.25 (3.32)  10.31 
iShares Global Healthcare ETF 0.00 0 per month 0.00  0.0177  2.26 (2.04)  7.20 
Fidelity MSCI Health Care ETF 0.00 0 per month 0.00  0.0094  3.14 (2.57)  9.16 

Investors are also interested in

Purchased over 300 shares
Active 2 days ago
Purchased over 20 shares
Active 2 days ago
Check also Virtus LifeSci Basic Forecasting Models to cross-verify your projections. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.